Pharmaceutical Technology Co., Ltd. Zhengzhou Singhai
Pharmaceutical Technology Co., Ltd. Zhengzhou Singhai is a high-tech enterprise based in Zhengzhou, China, focusing on medical information services, health care products, and health food technology research and development, as well as production and sales. The company is headquartered in Zhengzhou’s High-tech Zone and Technological Development Zone, with a workforce that includes sales personnel and management staff. This organization has established cooperative relationships for external OEM manufacturing, including patches, tablets, pills, capsules, and other dosage forms. In collaboration with Singhai Biotech of Germany, the company has pursued joint R&D efforts to develop new products, such as Brain Enuresis Kang, Ji-Min Xiaoliuwan pills, and bone-related capsules intended for personalized therapeutic applications. The enterprise emphasizes professional capabilities in health care, oncology, rheumatism, and bone-related product development, positioning itself as a modern, wide-ranging provider within the health industry.
From its inception, the company has embraced a philosophy centered on mutual benefit and integrity, aiming to provide expansive development space for global distributors and partners. The organization reports that some product lines, including Brain Enuresis Kang, Ji-Min Xiaoliuwan pills, and rheumatism/bone capsules, have been marketed domestically and exported to international markets such as Germany and the Middle East, thereby laying a foundation for broader international recognition under the “Singhai” name. The firm describes itself as expanding its national footprint through partnerships with agents and plans accelerated growth, with aspirations to connect with a wide network of business partners over the next few years. The narrative presents a forward-looking stance, highlighting a commitment to resource integration and collaboration with agents to pursue shared development and continued business success.
